Y-mabs enters into partnership with Uruguayan firm to launch cancer drugs in South America

Danish biotech firm Y-mabs Therapeutics has closed a Latin American distribution contract for the company's two cancer drugs.
Photo: Kelly Davidson Photography
Photo: Kelly Davidson Photography
BY ALBERT RØNNING-ANDERSSON AND ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY CATHERINE BRETT

Y-mabs Therapeutics has found distribution partners in South America for its two pediatric cancer drugs.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading